procarbazine has been researched along with Immunoblastic Lymphadenopathy in 7 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
Immunoblastic Lymphadenopathy: A disorder characterized by proliferation of arborizing small vessels, prominent immunoblastic proliferations and amorphous acidophilic interstitial material. Clinical manifestations include fever, sweats, weight loss, generalized lymphadenopathy and frequently hepatosplenomegaly.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To describe the clinical course of patients with angioimmunoblastic lymphadenopathy (AILD)-type lymphoma with a sequential treatment with prednisone and COPBLAM/IMVP-16." | 9.07 | Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group. ( Agthe, A; Brittinger, G; Engelhard, M; Griesser, H; Huhn, D; Kuse, R; Lennert, K; Schwerdtfeger, R; Siegert, W; Tiemann, M, 1992) |
| "To describe the clinical course of patients with angioimmunoblastic lymphadenopathy (AILD)-type lymphoma with a sequential treatment with prednisone and COPBLAM/IMVP-16." | 5.07 | Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group. ( Agthe, A; Brittinger, G; Engelhard, M; Griesser, H; Huhn, D; Kuse, R; Lennert, K; Schwerdtfeger, R; Siegert, W; Tiemann, M, 1992) |
| " Results of axillary lymph node, skin, and bone-marrow biopsies led to the diagnosis of angioimmunoblastic T-cell lymphoma (AITL), for which CEPP therapy (cyclophosphamide, etoposide, procarbazine, and prednisolone) was initiated." | 3.88 | Emergence of anti-mitochondrial M2 antibody in patient with angioimmunoblastic T-cell lymphoma. ( Hiroshima, Y; Joshita, S; Kawata, K; Kimura, T; Kobayashi, H; Mori, H; Tanaka, E; Tanaka, N; Umemura, T; Wada, S; Wakabayashi, SI, 2018) |
| "Because nonrandom acquired clonal chromosome abnormalities are a consistent feature of malignancies, our data suggest that AILD may be a malignant disease despite its original description as a benign proliferative process." | 1.26 | Nonrandom chromosome abnormalities in angioimmunoblastic lymphadenopathy. ( Haren, JM; Kaneko, Y; Larson, RA; Rowley, JD; Variakojis, D, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wakabayashi, SI | 1 |
| Kimura, T | 1 |
| Tanaka, N | 1 |
| Joshita, S | 1 |
| Kawata, K | 1 |
| Umemura, T | 1 |
| Hiroshima, Y | 1 |
| Mori, H | 1 |
| Kobayashi, H | 1 |
| Wada, S | 1 |
| Tanaka, E | 1 |
| Kaneko, Y | 1 |
| Larson, RA | 1 |
| Variakojis, D | 1 |
| Haren, JM | 1 |
| Rowley, JD | 1 |
| Lazza, M | 1 |
| Ramella, G | 1 |
| Cianferoni, MF | 1 |
| Rognoni, M | 1 |
| Bevilacqua, M | 1 |
| Cazzola, M | 1 |
| Bergamaschi, G | 1 |
| Castello, A | 1 |
| Del Forno, C | 1 |
| Dezza, L | 1 |
| Magrini, U | 1 |
| Ascari, E | 1 |
| Siegert, W | 1 |
| Agthe, A | 1 |
| Griesser, H | 1 |
| Schwerdtfeger, R | 1 |
| Brittinger, G | 1 |
| Engelhard, M | 1 |
| Kuse, R | 1 |
| Tiemann, M | 1 |
| Lennert, K | 1 |
| Huhn, D | 1 |
| Ganesan, TS | 1 |
| Dhaliwal, HS | 1 |
| Dorreen, MS | 1 |
| Stansfeld, AG | 1 |
| Habeshaw, JA | 1 |
| Lister, TA | 1 |
| Sahn, SA | 1 |
1 review available for procarbazine and Immunoblastic Lymphadenopathy
| Article | Year |
|---|---|
Immunologic diseases of the pleura.
Topics: Adult; Aged; Bromocriptine; Cardiac Surgical Procedures; Collagen Diseases; Dantrolene; Female; Gran | 1985 |
1 trial available for procarbazine and Immunoblastic Lymphadenopathy
| Article | Year |
|---|---|
Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophos | 1992 |
5 other studies available for procarbazine and Immunoblastic Lymphadenopathy
| Article | Year |
|---|---|
Emergence of anti-mitochondrial M2 antibody in patient with angioimmunoblastic T-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Cyclophosphamide; Etoposide; F | 2018 |
Nonrandom chromosome abnormalities in angioimmunoblastic lymphadenopathy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Aberrations; Cyclophosph | 1982 |
[A case of angioimmunoblastic lymphadenopathy with dysproteinemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Protein Disorders; Child; Humans; Immunoblasti | 1982 |
Kaposi's sarcoma complicating immunosuppressive therapy for angioimmunoblastic lymphadenopathy with dysproteinemia.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combinati | 1982 |
Angio-immunoblastic lymphadenopathy: a clinical, immunological and molecular study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Female; Humans | 1987 |